Association between genetic polymorphisms in cortactin and susceptibility to gastric cancer.
10.4174/astr.2015.89.2.74
- Author:
Dae Yong KIM
1
;
Joo Hyun LEE
;
Keun Young KIM
;
Dong Baek KANG
;
Won Cheol PARK
;
Soo Cheon CHAE
;
Jeong Kyun LEE
Author Information
1. Department of Surgery, Institute of Medical Science, Wonkwang University School of Medicine, Iksan, Korea. rjk@wonkwang.ac.kr
- Publication Type:Original Article
- Keywords:
Human CTTN protein;
Genetic polymorphism;
Stomach neoplasms
- MeSH:
Cell Movement;
Cortactin*;
Gene Frequency;
Genotype;
Humans;
Polymorphism, Genetic*;
Prognosis;
Stomach Neoplasms*
- From:Annals of Surgical Treatment and Research
2015;89(2):74-80
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Overexpression of cortactin (CTTN) in human tumors has been proposed to result in increased cell migration and metastatic potential. Here, we determined the frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms in apparently healthy subjects and gastric cancer patients, respectively, and the influence of the CTTN polymorphisms on gastric cancer susceptibility. METHODS: Blood samples were collected from 267 patients and 533 controls. CTTN g.-8748C>T and g.-9101C>T polymorphisms were determined using polymerase chain reaction-restriction fragment length polymorphism; the g.72C>T polymorphism was determined using the TaqMan method. RESULTS: Genotype frequencies of the CTTN g.-9101C>T polymorphism were 97.5% (TT), 2.5% (TC), and 0% (CC) in the patient group, and 98.6% (TT), 1.4% (TC), and 0% (CC) in the control group. Genotype frequencies of the CTTN g.-8748C>T polymorphism were 93.3% (TT), 6.8% (TC), and 0% (CC) in the patient group, and 94.2% (TT), 5.8% (TC), and 0% (CC) in the control group. Genotype frequencies of the CTTN g.72C>T polymorphism were 82.4% (CC), 17.2% (CT), and 0.4% (TT) in the patient group, and 78.0% (CC), 20.1% (CT), and 1.9% (TT) in the control group. Genotype and allele frequencies of the CTTN g.-9101C>T polymorphism differed significantly between the advanced gastric cancer and control groups. Patients with advanced gastric cancer, possessing the TC genotype, had a significantly poorer prognosis than the group with the TT genotype. CONCLUSION: The CTTN g.-9101C>T polymorphism might influence advanced gastric cancer susceptibility. However, the role of the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms requires careful interpretation and confirmation through larger studies.
